July, 2024
July 2024
Toni Choueiri: Our new IMDC paper in ESMO Open led by Kosuke Takemura
Jun 26, 2024, 15:13

Toni Choueiri: Our new IMDC paper in ESMO Open led by Kosuke Takemura

Toni Choueiri shared a post by Kosuke Takemura, Staff Urologist at Ganken Hospital, on X:

Our new IMDC paper in ESMO Open led by Kosuke Takemura! great job Kosuke and mentor Daniel Heng from Alberta Cancer foundation.
Follow our IMDC website at: imdconline.com and get to know the IMDC history with Daniel Heng..

Quoting Kosuke Takemura‘s post:

Just out in ESMO Open
Baseline lymphopenia (<1000 cells/μl) was found in 195/966 (20%) pts with metastatic kidney cancer receiving IO combo and was associated with worse oncologic outcomes. Special thanks to Toni Choueiri, Daniel Heng and other collaborators.

Kosuke Takemura

Read further.
Source: Toni Choueiri/X and Kosuke Takemura/X

Toni Choueiri is the Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute (DFCI), co-leader of the Kidney Cancer Program at Dana-Farber/Harvard Cancer Center, and the Jerome and Nancy Kohlberg Chair and Professor of Medicine at Harvard Medical School. He is the Medical Director of International Strategic Initiatives at Dana-Farber and past President of the Medical Staff at DFCI (2016-2018).

He received the George Canellos Award for Excellence in Clinical Investigation and Patient Care from DFCI in 2013, the Eugene Schonfeld Award from the Kidney Cancer Association (KCA) in 2016, and is a 2021 Giants of Cancer Care inductee. He serves on the National Comprehensive Cancer Network (NCCN) Kidney Cancer Panel, KidneyCan Board, the National Cancer Institute (NCI) GU Steering Committee, and is past Chairman (2015-2018) of the Medical and Scientific Steering Committee of the KCA.

Dr. Choueiri is an elected member of the American Society of Clinical Investigation (ASCI). In addition, he is an Aresty Scholar from the Wharton School of Business at the University of Pennsylvania.